ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2017 American Transplant Congress

    Manning the Gap: Using Technology to Reduce Barriers in Access to Renal Transplantation Waiting List Across Dialysis Facilities.

    G. Ferreira,1 K. Bastos,2 E. Barbeta,2 B. Pereira,2 G. Souza,1 M. de Souza,1 V. Colares.1

    1Kideny Transplant UPI, Santa Casa de Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil; 2Nephrology, CTDR, Juiz de Fora, Minas Gerais, Brazil

    Background:Pervasive disparities in access to kidney transplantation persist despite decades of recognition and efforts to improve equity in transplant access. Using technology to reduce the…
  • 2017 American Transplant Congress

    De Novo, Non-Donor Specific HLA Antibodies Are Associated with Inferior Allograft Outcomes After Kidney and Simultaneous Kidney-Pancreas Transplantation.

    S. Hassan,1 G. Lucisano,1 E. Santos,2 D. McKeown,3 D. Goodall,1 A. Gueret-Wardle,1 A. McLean,1 P. Brooks,2 M. Willicombe,1 D. Taube.1

    1Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, United Kingdom; 2Histocompatibility and Immunogenetics, Imperial College Healthcare NHS Trust, London, United Kingdom; 3Blood Transfusion, Imperial College Healthcare NHS Trust, London, United Kingdom

    Introduction: Donor specific antibodies [DSAs] occurring after transplantation are associated with poorer outcomes. However the significance of non-donor directed HLA antibodies [ndHLAs] after transplantation in…
  • 2017 American Transplant Congress

    Impact of Antihypertensive (AHT) Choice and Advagraf® Dose on Interstitial Fibrosis/Tubular Atrophy (IF/TA) and IF/TA Progression in Renal Allografts 24 Months Post-Transplantation (Tx).

    S. Cockfield,1 D. Rush,2 S. Wilson,3 J. Howell,4 FKC-014 Study Group.

    1University of Alberta Hospital, Edmonton, AB, Canada; 2Health Sciences Centre, Winnipeg, MB, Canada; 3Astellas Pharma Global Development, Northbrook, IL; 4Astellas Pharma Global Development, Markham, ON, Canada

    IF/TA may be delayed using ACEi- or ARB-type AHTs, which target the renin-angiotensin system (RAS), as well as by optimizing tacrolimus (TAC) exposure. The effect…
  • 2017 American Transplant Congress

    Is Deceased Donor Kidney Transplantation (DDTX) Justified in Patients with More Than 10 Years of Pre-TX Dialysis Exposure?

    C. Rose, J. Gill, J. Lesage, Y. Joffres, J. Gill.

    UBC, Vancouver, Canada

    Background: The new kidney allocation system (KAS) led to an increase in DDTX among patients with ≥10 years of pre-TX dialysis exposure. We aimed to…
  • 2017 American Transplant Congress

    Ectopic Lymphoid Structures Are Present in Type I T-Cell Mediated Kidney Transplant Rejection.

    K. de Leur,1,2 M. Clahsen-van Groningen,3 G. de Graav,1 D. Hesselink,1 J. Samsom,4 C. Baan,1 K. Boer.1

    1Internal Medicine, Erasmus MC, Rotterdam, Netherlands; 2Surgery, Division HPB and Transplant Surgery, Erasmus MC, Rotterdam, Netherlands; 3Pathology, Erasmus MC, Rotterdam, Netherlands; 4Pediatrics, Erasmus MC, Rotterdam, Netherlands

    BackgroundIn renal transplantation, many allograft recipients develop donor-specific antibodies associated with an increased risk for graft rejection. Current immunosuppressive agents are principally aimed at T-cell-mediated…
  • 2017 American Transplant Congress

    Post-Donation Experiences of Non-Directed (Altruistic) Living Kidney Donors in the United States.

    A. Maghen,1 G. Vargas,1 S. Connor,1 S. Nassiri,1 E. Hicks,2 L. Kwan,1 S. Maliski,3 J. Veale.

    1Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; 2Oregon Health and Science University, Portland, OR; 3University of Kansas Medical Center School of Nursing, Kansas City, KS

    A. Non-directed donors (NDDs) can potentially help alleviate the overburdened kidney transplant waiting list while also improve the quality of life for patients with end-stage…
  • 2017 American Transplant Congress

    Vendor to Center in 0-60: A Safe and Effective Blueprint for Creating an In-House On-Call System for Organ Offers.

    K. Driggers, J. Davenport, D. Cassidy, L. Curry, A. Milling, A. Hauser, H. Crego, P. Baliga, N. Pilch, D. Dubay, J. Anderson.

    Transplant, Medical University of South Carolina, Charleston, SC

    Introduction: Our center returned to an in-house nurse coordinator on-call program 7/2016 after using a vendor from 11/2012 to 7/2016 for organ allocation. It was…
  • 2017 American Transplant Congress

    EPTS Is a Poor Predictor of Post-KT Mortality for Older Recipients.

    M. McAdams DeMarco, X. Luo, A. Massie, D. Segev.

    Johns Hopkins, Baltimore, MD

    Background:The new kidney allocation system (KAS) is meant to better match longevity of recipients and allografts. The United Network for Organ Sharing (UNOS) decided that…
  • 2017 American Transplant Congress

    Performance-Based vs. Self-Reported Functional Assessment on Outcomes After Kidney Transplant.

    K. Tibaldi, N. Dhillon, R. Goldberg, H. Paniagua, A. Patel.

    Renal and Pancreas Transplant Department, Saint Barnabas Medical Center, Livingston, NJ

    Reduced functional capacity (FC) is associated with poor outcomes and early hospital readmission after kidney transplant (KT). The aim of the study was to determine…
  • 2017 American Transplant Congress

    Living Kidney Donors: Battling High Attrition Rates During Evaluation Process.

    J. Verbesey, A. Bacigalupo, A. Gilbert, A. Li, C. Zuttermeister, M. Grafals, J. Moore, B. Javaid, P. Abrams, S. Ghasemian, M. Cooper.

    MedStar Georgetown Transplant Institute, Washington DC

    With an ever increasing kidney waiting list, a major goal is to expand living donor transplantation (LD). LD increases volume and provides higher quality, longer…
  • « Previous Page
  • 1
  • …
  • 339
  • 340
  • 341
  • 342
  • 343
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences